clarithromycin has been researched along with Coronary Artery Disease in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (30.00) | 29.6817 |
2010's | 5 (50.00) | 24.3611 |
2020's | 2 (20.00) | 2.80 |
Authors | Studies |
---|---|
Lee, TH; Liao, PC; Lin, CK; Lin, CL | 1 |
Ärnlöv, J; Gluud, C; Harutyunyan, M; Hilden, J; Jakobsen, JC; Jensen, GB; Johansen, JS; Kastrup, J; Kjøller, E; Larsson, A; Sajadieh, A; Schroder, J; Winkel, P | 1 |
Bjerre, M; Flyvbjerg, A; Gluud, C; Hansen, JF; Hilden, J; Jensen, GB; Kastrup, J; Kjøller, E; Kolmos, HJ; Skoog, M; Winkel, P | 1 |
Gluud, C; Hansen, JF; Hilden, J; Jensen, GB; Kastrup, J; Kjøller, E; Kolmos, HJ; Lindschou, J; Skoog, M; Winkel, P | 1 |
Li, C; Li, X; Liu, G; Wang, M; Wang, Z; Zhou, L | 1 |
Fischer Hansen, J; Gluud, C; Hildebrandt, P; Hilden, J; Jensen, GB; Jespersen, CM; Kastrup, J; Kjøller, E; Kolmos, HJ; Winkel, P | 1 |
Berg, HF; Kluytmans, JA; Maraha, B; Peeters, MF; Scheffer, GJ | 1 |
Muhlestein, JB | 1 |
1 review(s) available for clarithromycin and Coronary Artery Disease
Article | Year |
---|---|
Antibiotic treatment of atherosclerosis.
Topics: Animals; Anti-Bacterial Agents; Arteriosclerosis; Azithromycin; C-Reactive Protein; Cardiovascular Diseases; Chlamydophila Infections; Chlamydophila pneumoniae; Clarithromycin; Coronary Artery Disease; Coronary Restenosis; Diet, Atherogenic; Fluoroquinolones; Gatifloxacin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Models, Animal; Myocardial Ischemia; Rabbits; Randomized Controlled Trials as Topic; Roxithromycin; Treatment Outcome | 2003 |
3 trial(s) available for clarithromycin and Coronary Artery Disease
Article | Year |
---|---|
Prognosis and Reclassification by YKL-40 in Stable Coronary Artery Disease.
Topics: Aged; Anti-Bacterial Agents; Biomarkers; C-Reactive Protein; Chitinase-3-Like Protein 1; Clarithromycin; Coronary Artery Disease; Female; Follow-Up Studies; Humans; Male; Middle Aged; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Survival Rate | 2020 |
Clarithromycin for stable coronary heart disease increases all-cause and cardiovascular mortality and cerebrovascular morbidity over 10years in the CLARICOR randomised, blinded clinical trial.
Topics: Aged; Anti-Bacterial Agents; Cause of Death; Clarithromycin; Coronary Artery Disease; Denmark; Female; Follow-Up Studies; Forecasting; Humans; Male; Morbidity; Retrospective Studies; Single-Blind Method; Stroke | 2015 |
Effect of clarithromycin on inflammatory markers in patients with atherosclerosis.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Biomarkers; C-Reactive Protein; Clarithromycin; Coronary Artery Bypass; Coronary Artery Disease; Double-Blind Method; Female; Humans; Inflammation; Interleukin-6; Interleukin-8; Male; Middle Aged; Prospective Studies; Receptors, Interleukin-2; Treatment Failure; Tumor Necrosis Factor-alpha | 2003 |
6 other study(ies) available for clarithromycin and Coronary Artery Disease
Article | Year |
---|---|
Cardiac events after using clarithromycin for anti-Helicobacter pylori therapy in patients with coronary artery disease.
Topics: Anti-Bacterial Agents; Clarithromycin; Coronary Artery Disease; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Retrospective Studies | 2023 |
Clarithromycin in patients with coronary artery disease.
Topics: Anti-Bacterial Agents; Arrhythmias, Cardiac; Bacterial Infections; Clarithromycin; Coronary Artery Disease; Humans; Risk Factors | 2018 |
Osteoprotegerin independently predicts mortality in patients with stable coronary artery disease: the CLARICOR trial.
Topics: Aged; Anti-Bacterial Agents; Clarithromycin; Coronary Artery Disease; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multicenter Studies as Topic; Osteoprotegerin; Prognosis; Proportional Hazards Models; Randomized Controlled Trials as Topic; Risk Factors | 2014 |
Macrolides use and the risk of sudden cardiac death.
Topics: Anti-Bacterial Agents; Arrhythmias, Cardiac; Azithromycin; Clarithromycin; Coronary Artery Disease; Coronary Disease; Death, Sudden, Cardiac; Erythromycin; Humans; Macrolides; Plaque, Atherosclerotic; Risk Factors; Torsades de Pointes | 2016 |
Excess sudden cardiac deaths after short-term clarithromycin administration in the CLARICOR trial: why is this so, and why are statins protective?
Topics: Anti-Bacterial Agents; Clarithromycin; Coronary Artery Disease; Death, Sudden, Cardiac; Denmark; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Randomized Controlled Trials as Topic | 2011 |
Antibiotics for heart health?
Topics: Anti-Bacterial Agents; Bacterial Infections; Chest Pain; Clarithromycin; Coronary Artery Disease; Humans; Inflammation | 2002 |